Alliances & Partnerships

Since 1993, we have entered into more than 20 major partnerships that encompass in- and out-licensing, collaborative research, co-development and co-promotion agreements.

We bring significant strengths and experience as a partner: our history as a biotech company, a bold entrepreneurial drive, the broad resources and network of a global pharmaceutical company and a proven development track record.

"Partnerships and collaborations are integral to our growth and aspiration to cure cancer. Our history proves it and our forward vision demands it."
Tariq Kassum, M.D.
Vice President, Corporate Development Oncology

Areas of Collaboration

We have a particular interest in pursuing science that fundamentally changes the way the oncology community approaches the treatment of cancer. We welcome opportunities to collaborate on discoveries in the following areas:

  • Indications of Interest: We are interested in new therapies for oncology, hematology-oncology and hematology indications.
  • Stage of Development: We will consider breakthrough science in the preclinical or clinical phase.
  • Commercial relationship: We are primarily focused on global partnerships. For marketed or near-marketed products, we will also consider partnerships that are limited to Japan given Takeda's preeminent position and ability to maximize commercial value of products in the Japanese market.

We are open to different collaboration structures, and always seek to address both our own and our partners' strategic needs in every collaboration we pursue.

To connect with one of our Business Development professionals, please click here.

To find out more about how to partner with Takeda, please click here.